Clinical Trial

BEETROOT JUICE INTAKE in POSTMENOPAUSAL HYPERTENSIVE WOMEN

Study acronym: EBJIPHW
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to verify the hemodynamic and biomarker responses of beetroot juice intake in postmenopausal women with hypertension. The main questions it aims to answer are: Is beetroot juice dose related to better hemodynamic responses in hypertensive postmenopausal women? Is beetroot juice dose related to better oxidative stress profile responses in hypertensive postmenopausal women? The investigators will conduct a parallel clinical study with 10 days of intervention, in which 48 women will be randomized into 3 groups: 1) Two shots of beetroot juice intake per day (800mg of NO3-); 2) One shot of beetroot juice intake per day (400mg of NO3-); 3) placebo intake (beetroot juice without NO3-).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-30; most recent amendment 2024-09-19.
Trial Details
NCT Number NCT06584331
Lead Sponsor Federal University of Uberlandia
Conditions Hypertension, Menopause
Enrollment 48 participants
Start Date 2024-08-07
Primary Completion 2025-07 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-23